Fortis Healthcare Limited

New Delhi, India

37 Locations

Fortis Healthcare Limited is one of India's leading private hospital networks, known for providing a wide range of healthcare services across various specialties. With a commitment to delivering quality care, Fortis operates numerous hospitals and clinics, utilizing advanced medical technology and a team of experienced healthcare professionals to ensure exceptional patient outcomes.

CCI Score

-22.19

June 9

Latest Event

Appointment of Leo Puri as Chairman

Fortis Healthcare Limited has appointed Mr. Leo Puri as the Independent and Non-Executive Chairman of its Board of Directors, effective December 27, 2024. His extensive leadership experience from roles at JP Morgan Chase, McKinsey, and other major organizations is expected to enhance the company’s strategic direction, governance, and commitment to quality healthcare access and employment creation in line with India’s National Health Policy.

Take Action

So what can you do? It's time to make tough choices. Where will you cast your vote?

Shop Alternatives SEE ALL: Birmingham Community Healthcare NHS Trust

Indonesian Hospital

Intermountain Health
Use Your Voice OTHER TOOLS
Investigate
Share the Score SUPPORT CCI

ACCOMPLICE

Fortis Healthcare Limited is currently rated as an Accomplice.

-20 to -29 CCI Score

These companies profit from authoritarian practices through their business dealings. Although they may not be directly enforcing oppressive policies, their actions contribute to the economic and operational sustenance of authoritarian regimes.

Latest Events

DEC

27

2024

Appointment of Leo Puri as Chairman
38.24

Fortis Healthcare Limited has appointed Mr. Leo Puri as the Independent and Non-Executive Chairman of its Board of Directors, effective December 27, 2024. His extensive leadership experience from roles at JP Morgan Chase, McKinsey, and other major organizations is expected to enhance the company’s strategic direction, governance, and commitment to quality healthcare access and employment creation in line with India’s National Health Policy.
+40

Executive Political Engagement

June 8

The appointment of Leo Puri, an experienced leader with a track record in high-impact governance roles, is seen as a step toward enhancing corporate transparency, accountability, and ethical leadership. His independent and non-executive status and his prior board roles signal a commitment to progressive practices and improved strategic oversight, which aligns with anti-fascist values by fostering responsible corporate management.

Fortis Healthcare appoints Leo Puri as Chairman of Board of Directors
SEP

22

2022

Controversial Deal and Legal Battle Affecting Expansion Plans
-27.10

Fortis Healthcare is entangled in a prolonged legal dispute rooted in its 2018 preferential allotment of shares to Malaysia-based IHH Healthcare. The case, which has seen a Supreme Court stay on the share sale and resulted in jail terms for former promoters, is raising serious concerns about corporate governance and the company’s near-term strategic expansion.
-40

Business Practices and Ethical Responsibility

June 8

The article outlines Fortis Healthcare's preferential allotment to IHH Healthcare and the ensuing legal challenges, which cast doubt on its corporate governance and ethical business practices. This controversy suggests mismanagement and raises questions about accountability in business decisions.

Fortis-IHH healthcare case: Why is the trouble and what next?
-30

Economic and Structural Influence

June 8

The ongoing legal issues and uncertainty around the share sale are affecting Fortis Healthcare's economic and structural stability, potentially hampering its expansion plans and investor confidence, which is reflected by its negative impact on economic influence.

Fortis-IHH healthcare case: Why is the trouble and what next?
JAN

15

2022

Settlement Payment to SEBI over Fund Diversion
-49.82

Three senior officials and directors of Fortis Healthcare, along with Religare Finvest, paid Rs 4.34 crore to SEBI to settle allegations regarding the diversion of public funds by the company's promoters and related entities.
-70

Business Practices and Ethical Responsibility

June 8

The settlement payment following allegations of fund diversion indicates serious lapses in ethical business practices and corporate governance. Such actions undermine stakeholder trust and accountability, reflecting irresponsible management that can indirectly erode democratic and transparent corporate behavior.

Three senior officials of Fortis along with Religare Finvest pay 4.3 Cr to settle a case with SEBI
MAY

18

2020

SEBI Penalizes Fortis Healthcare Holdings for Financial Misconduct
-48.22

SEBI imposed penalties totaling Rs 38.75 crore on 32 entities, including Fortis Healthcare Holdings, in connection with an investigation into alleged diversion of funds and misrepresentations in financial statements dating back to 2018.
-80

Business Practices and Ethical Responsibility

June 8

The penalties imposed by SEBI highlight serious unethical business practices, including fraudulent diversion of funds and misrepresentation of financial data. These actions undermine investor trust and market integrity, reflecting negatively on the company's ethical responsibilities.

Fortis Healthcare case: SEBI slaps penalties worth Rs 38.75 cr on 32 entities
FEB

13

2018

Sebi Investigates Fortis Healthcare’s Regulatory Practices
-24.04

Market regulator SEBI announced an investigation into Fortis Healthcare amid allegations that promoter-linked companies were involved in the transfer of funds without board approval, with reports suggesting that approximately $78 million was moved improperly. The company has disputed claims and emphasized that secured investments and repayment processes are in place, but regulatory concerns persist.
-50

Business Practices and Ethical Responsibility

June 8

The investigation by SEBI into alleged lapses in internal controls and fund transfer practices raises serious concerns about Fortis Healthcare’s business practices and ethical responsibility. The reported transfer of significant funds without board approval reflects potential governance failures that undermine transparency and accountability.

Sebi says looking into Fortis Healthcare matter